Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs )
Also on site :
- U.S. tariffs on China won't change again, Lutnick says
- Russia’s Oil Profits Tumble as Prices Fall and Sanctions Hit
- Inflation probably inched up in May as trade war got underway